Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-03-16

Clinical Trial Update: Dapagliflozin in Type 1 Diabetes [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for dapagliflozin in type 1 diabetes (completed).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dapagliflozin (dapagliflozin)

Snippet

Sponsor: Medical University Innsbruck | Conditions: Fasting Glucose, Glucose Excursion | Phase 4 | Status: COMPLETED